Evidence map›Paper›PMID 25695642›Full record

ArticleCell cycle (Georgetown, Tex.)2015

Stable maintenance of de novo assembled human artificial chromosomes in embryonic stem cells and their differentiated progeny in mice.

Mikhail Liskovykh, Sergey Ponomartsev, Elena Popova, Michael Bader, Natalay Kouprina, Vladimir Larionov, Natalia Alenina, Alexey Tomilin

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Human AlphoidCells · 2020
    Article
  8. Article
  9. TAR Cloning: Perspectives for Functional Genomics, Biomedicine, and Biotechnology.Molecular therapy. Methods & clinical development · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Moving toward a higher efficiency of microcell-mediated chromosome transfer.Molecular therapy. Methods & clinical development · 2016
    Article
  16. Human artificial chromosomes for future biomedicine.Cell cycle (Georgetown, Tex.) · 2015
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Mikhail Liskovykha Institute of Cytology Russian Academy of Sciences ; St-Petersburg , Russia.
Sergey Ponomartsev
Elena Popova
Michael Bader
Natalay Kouprina
Vladimir Larionov
Natalia Alenina
Alexey Tomilin
Max Delbrück Center · DENational Cancer Institute · USHelios Hospital Berlin-Buch · DEInstitute of Cytology · RUNational Institutes of Health · USSkolkovo Moscow School of Management · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

De novo assembled alphoid(tetO)-type human artificial chromosomes (HACs) represent a novel promising generation of high capacity episomal vectors. Their function and persistence, and any adverse effects, in various cell types in live animals, have not, however, been explored. In this study we transferred the alphoid(tetO)-HAC into mouse ES cells and assessed whether the presence of this extra chromosome affects their pluripotent properties. Alphoid(tetO)-HAC-bearing ES cells were indistinguishable from their wild-type counterparts: they retained self-renewal potential and full capacity for multilineage differentiation during mouse development, whereas the HAC itself was mitotically and transcriptionally stable during this process. Our data provide the first example of fully synthetic DNA behaving like a normal chromosome in cells of living animals. It also opens a new perspective into functional genetic studies in laboratory animals as well as stem cell-based regenerative medicine.

Indexed as

Cell DifferentiationAnimalsBlastocystCHO CellsChromosomes, Artificial, HumanCricetinaeCricetulusFemaleGenetic TherapyGene Transfer TechniquesHumansImmunohistochemistryIn Situ Hybridization, FluorescenceMiceMice, Inbred C57BLMouse Embryonic Stem CellsBsd, blasticidinDAPI, 4′, 6-Diamidino-2-Phenylindoledpc, days post coitumEGFP, enhanced green fluorescent proteinembryonic stem cellsES cells, embryonic stem cellsFISH, fluorescent in situ hybridizationgene therapyHAC, human artificial chromosomeHAT, hypoxanthine-aminopterin-thymidinehuman artificial chromosomesiPS cells, induced pluripotent stem cellsMMCT, microcell mediated chromosome transferPBS, phosphate buffered salinePFA, paraformaldehyde

Identifiers

PMID25695642
PMCPMC4614155
OpenAlexW1511659446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.